Descovy 200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FEDWW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,848
Award facts
- Contract value 100% obligated
- $41,847.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $41,847.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (quantity 30s) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-set-aside contract represents a pharmaceutical delivery under the company's broader relationship with DLA's medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider to federal medical procurement systems, particularly supporting military and veteran healthcare operations. The delivery order is a child contract executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
This contract exemplifies AmerisourceBergen Drug Corp's role as a primary vendor within DLA's pharmaceutical procurement framework, which supports the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems globally. The company's extensive portfolio of competitively awarded contracts demonstrates its capability to deliver diverse pharmaceutical products, medical supplies, vaccines, and specialty medications across multiple therapeutic domains. The DLA Troop Support is currently planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, indicating the strategic importance of reliable pharmaceutical distribution to military healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DB25FEDWW?
SPE2DB25FEDWW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FEDWW worth?
The government has obligated $41,848 on SPE2DB25FEDWW.
Is contract SPE2DB25FEDWW an order under another contract?
Yes. SPE2DB25FEDWW is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEDWW competed?
The extent of competition for SPE2DB25FEDWW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award